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Synopsis
Erv1 is an FAD-dependent thiol oxidase of the ERV (essential for respiration and viability)/ALR (augmenter of liver
regeneration) sub-family and an essential component of the mitochondrial import and assembly pathway. Erv1 con-
tains six tryptophan residues, which are all located in the highly conserved C-terminal FAD-binding domain. Though
important structural roles were predicted for the invariable Trp95, no experimental study has been reported. In the
present study, we investigated the structural and functional roles of individual tryptophan residues of Erv1. Six single
tryptophan-to-phenylalanine yeast mutant strains were generated and their effects on cell viability were tested at
various temperatures. Then, the mutants were purified from Escherichia coli. Their effects on folding, FAD-binding
and Erv1 activity were characterized. Our results showed that Erv1W95F has the strongest effect on the stability and
function of Erv1 and followed by Erv1W183F. Erv1W95F results in a decrease in the Tm of Erv1 by 23 ◦C, a significant
loss of the oxidase activity and thus causing cell growth defects at both 30 ◦C and 37 ◦C. Erv1W183F induces changes
in the oligomerization state of Erv1, along with a pronounced effect on the stability of Erv1 and its function at 37 ◦C,
whereas the other mutants had no clear effect on the function of Erv1 including the highly conserved Trp157 mutant.
Finally, computational analysis indicates that Trp95 plays a key role in stabilizing the isoalloxazine ring to interact with
Cys133. Taken together, the present study provided important insights into the molecular mechanism of how thiol
oxidases use FAD in catalysing disulfide bond formation.
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INTRODUCTION
Erv1 (essential for respiration and viability 1) is an essential com-
ponent of the mitochondrial import and assembly (MIA) pathway,
playing a critical role during import and oxidative folding of the
mitochondrial intermembrane space (IMS) proteins [1–3]. In the
MIA pathway, Mia40 acts as a thiol oxidoreductase and import
receptor, interacting directly with the substrates of the pathway
{e.g. Tim9 (translocase of inner membrane 9), Tim10, Cox17
(cytochrome oxidase 17) and Ccs1 (copper chaperone for su-
peroxide dismutase 1)}. Erv1 is a FAD-dependent thiol oxidase
belonging to the single domain ERV/ALR (augmenter of liver
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regeneration) oxidase family. It functions downstream of Mia40,
catalysing re-oxidation of the reduced Mia40 and transferring
electrons (via FAD) to molecular oxygen and/or cytochrome c
[4–10].
Saccharomyces cerevisiae Erv1 has a total of 189 amino acids
including a highly conserved (among ERV/ALR family) FAD-
binding domain of approximately 100 amino acids at the C-
terminus (Figure 1). There are six conserved cysteine residues
forming three pairs of disulfide bonds, with four of the cysteine
residues located in the FAD-binding domain. Several structures
of the FAD-binding domain of ERV/ALR proteins have been
published [10–15], in which they are all crystallized as head-
to-tail homodimers. Each subunit contains a four-helical bundle
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Figure 1 Cell viability of the Erv1 WT and tryptophan mutant strains
(a) Sequence alignment of Erv/ALR proteins. Sc: S. cerevisiae, Hs: Homo sapiens, Rn: Rattus norvegicus, At: Arabidopsis
thaliana. Tryptophan residues are highlighted in grey and numbered for yeast Erv1. (b) The X-ray crystal structure of
yeast Erv1 core domain residues 84–188 with FAD and the six tryptophan residues shown (PDB code: 4E0OH) [11]. The
structures were generated using the PyMOL VMD software. (c) Zoomed in structure of Erv1 showing how Trp95 is involved
in both H-bonds and π -stacking interactions to stabilize FAD binding.
(H1–H4) that harbours the FAD cofactor and an additional (fifth)
single-turn helix (Figure 1). The FAD-binding domain acts as a
catalytic core (also called catalytic domain) containing a CXXC
redox centre disulfide (Cys130–Cys133), located proximal to the
isoalloxazine ring of FAD cofactor and a C-terminal CX16C struc-
tural disulfide. The shuttle disulfide (Cys30–Cys33) of Erv1 is
located in the non-conserved N-terminal domain. It accepts the
electrons from reduced Mia40 and transfers them to the active-site
disulphide (C130-C133) and then in turn to the cofactor FAD and
cytochrome c and/or molecular oxygen [4,16–19]. Erv1 and ALR
employ a similar catalytic mechanism which involves several
intermediate states, including a shuttle disulfide reduced state,
S→FAD charge-transfer complexes and an FADH2-Erv1 state,
during their catalytic cycle [17,20–22]. Whilst the shuttle and
the active-site disulfides are functionally essential, the conserved
CX16C disulfide (C159-C176) plays an important role in stabilizing
the folding of Erv1 [6,23].
Tryptophan plays important roles in protein stability despite
its scarcity in proteins. Erv1 has six tryptophan residues that are
all located in the C-terminal FAD-binding domain making the
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domain tryptophan-rich. Among them Trp95, Trp157 and Trp183
are highly conserved across the ERV/ALR family; Trp187 is par-
tially conserved; whereas Trp132 and Trp179 are not conserved
(Figure 1a). Trp95, Trp132 and Trp157 are located in H1, H3 and
H4 respectively; Trp179 and Trp183 are in the fifth single-turn helix
(H5) and Trp187 is located at the very end of C-terminus, the third
residue from the end (Figure 1a). Interestingly, the highly con-
served Trp183 is next to the highly conserved residue Arg182,
whose mutation in the human homologue ALR caused diseases.
In 2009, Di Fonzo et al. [24] reported the first disease-associated
mutant of ALR, in which a single conserved arginine to his-
tidine substitution (ALRR194H) caused an autosomal recessive
myopathy. Structural and functional study of the corresponding
Erv1R182H mutant showed that Arg182 plays an important role in
the folding and FAD binding of Erv1 [25]. Although the oligo-
merization state of Erv1 in vivo is unclear, our recent in vitro
study showed that whilst the purified full-length Erv1 formed a
stable tetramer, the Erv1R182H mutant was a homodimer under the
same experimental condition [25]. Visualization of the structures
of Erv1 [11] indicates that both Trp 95 and Trp183 side chains are
involved in stabilizing the cofactor binding. Firstly, Trp95 forms
an H-bond with the OH group of the ribitol moiety of FAD and
Trp183 forms an H-bond with the nitrogen of adenine moiety of
FAD using its side chain, suggesting a role similar to Arg182 in
stabilizing FAD binding. Secondly, both Trp95 and Trp183 seem
to play an important part in forming a series of π stackings with
the cofactor FAD, involving the isoalloxazine ring of FAD, side
chains of Trp95, Tyr128, His162, Phe174, Trp183 and the adenine
ring of FAD (Figure 1c). In particular, the invariable Trp95 of
ERV/ALR and Ero1 proteins locates in the centre of the aromatic
stacking and is sandwiched between the isoalloxazine ring of
FAD and the invariable His162 [11,13,26,27]. Though an import-
ant role can be assumed for some of the tryptophan residues, no
experimental study on the importance of the tryptophan residues
and the π stackings in ERV/ALR enzymes’ structure and function
has been reported.
In the present study, we investigated the structural and func-
tional roles of all six tryptophan residues of Erv1 with a focus
on Trp95, using biochemical and biophysical methods, as well
as computational and yeast genetic approaches. First, a set of
six single tryptophan-to-phenylalanine yeast mutant strains were
generated and their effects on cell viability were tested at various
temperatures. Then, the tryptophan mutants were expressed and
purified from Escherichia coli. Their effects on Erv1 folding,
FAD-binding, stability and oxidase activity were studied using
size exclusion chromatography, spectroscopic (absorption, CD
and FAD fluorescence) and oxygen consumption analyses. Our
results show that except Erv1W183F, all mutants were purified as
a tetramer like the wild-type (WT) protein, whereas Erv1W183F
was a dimer. Erv1W95F has the strongest effect on the stability
and hence the function of Erv1, which is followed by Erv1W183F.
Though the other mutants also result in observable effects on the
folding and stability of Erv1, there is no obvious defect in the
oxidase activity of the protein, including the highly conserved
Trp157 mutant. Finally, computational analysis was performed to
provide insight into the FAD-binding energy landscape at the
atomic level, which assisted our understanding of the molecular
mechanism by which Erv1W95F causes the functional defect of
Erv1.
EXPERIMENTAL
Site-directed mutagenesis
A construct encoding C-terminally LE(H)6-tagged full-length,
WT Erv1 cloned into E. coli expression vector pET24a(+)
(Novagen) using the Nde1 and Xho1 restriction sites was used as
DNA template [28] to generate all mutant constructs for protein
purification work in the present study. For yeast studies, ERV1
together with endogenous promoter and terminator regions was
inserted into the centromeric plasmid pRS414 as previously de-
scribed [17] and was used as a DNA template for mutagenesis.
Tryptophan-to-phenylalanine mutations were introduced by PCR
using overlapping primer pairs containing the desired mutation
point. Plasmid DNA constructs with the correct mutation was
verified by DNA sequencing.
Protein purification
WT Erv1 and tryptophan mutants were expressed in E. coli strain
Rosetta-gamiTM 2 (Novagen) and purified as previously described
[17,25]. Briefly, protein was expressed in the presence of 0.5 mM
IPTG and 10 μM FAD at 16 ◦C for 16–20 h. Induced cell pel-
lets resuspended in buffer A (150 mM NaCl, 50 mM Tris/HCl,
pH 7.4) containing 5 mM imidazole, 50 μM FAD and one tablet
of EDTA-free protease inhibitor cocktail (Roche) were lysed by
sonication on ice. The supernatant fraction containing LE(H)6-
tagged Erv1 was bound to 2–3 ml of Ni2 + -charged histidine.
Bind resin (Novagen) pre-equilibrated with binding buffer. Fol-
lowing a washing step with 20–30 ml of wash buffer (buffer A
plus 20 mM imidazole), the protein was eluted with 4–6 ml of
elution buffer (buffer A containing 500 mM imidazole). FAD
(100 μM) was added to eluted proteins before storage at − 80 ◦C
until further use. The affinity-purified proteins were further sep-
arated for use in in vitro studies by gel filtration chromatography
using a Superdex 200 (or Superdex 75) 10/30 column connec-
ted to an ¨AKTA-FPLC system (GE Healthcare) at 4 ◦C in BAE
(150 mM NaCl, 50 mM Tris/HCl, 1 mM EDTA, pH 7.4).
UV-visible spectroscopy
Absorption spectra were recorded from 250 to 700 nm, at 1 nm
intervals, in a 1 cm path-length quartz cuvette using a Cary 300
Bio UV-Visible spectrophotometer (Varian Ltd.). Measurement
of the molar extinction coefficient was done in BAE as previously
described [6,7]. The calculated molar extinction coefficients are
summarized in Table 1. The FAD content of the WT and mutant
Erv1 was calculated based on the eqn (1), an extinction coeffi-
cient for free FAD (fFAD) of 11.3 mM-1 cm-1 and the absorption
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Table 1 Summary of the properties of FAD-binding and stability
of the WT and mutant Erv1
The parameters were determined in BAE at pH 7.4 under the same
conditions for all proteins as described in the ‘Experimental’ section.
a. Tm determined based on FAD fluorescence; b. Tm determined based
on CD at 222 nm. Errors represent means +− SE, n2.
Erv1 λmax (nm) ε (mM-1cm-1) FAD% Tm (◦C)* Tm (◦C)†
WT 460 +− 1 12.3 95 +− 3 64 +− 2 66 +− 2
W95F 458 +− 2 11.8 93 +− 5 42 +− 2 45 +− 3
W132F 460 +− 1 12.2 94 +− 3 64 +− 2 65 +− 2
W157F 460 +− 1 12.3 92 +− 3 54 +− 2 55 +− 2
W179F 460 +− 1 12.3 100 +− 3 57 +− 2 56 +− 2
W183F 459 +− 1 11.6 71 +− 3 51 +− 2 50 +− 2
W187F 461 +− 1 11.7 94 +− 3 59 +− 2 58 +− 2
spectrum of Erv1 or mutants in BAE plus 1 % SDS. 1
F AD% = ε280 × A450
11.3 × (A280 − 1.82 × A450) (1)
ε280 is the extinction coefficient of the apoprotein; 42.54 mM-1
cm-1for the WT and 36.85 mM-1 cm-1 for the single tryptophan-
to-phenylalanine mutants of Erv1. A280 and A450 are absorbance
at 280 and 450 nm respectively. The ratio of ε280/ε450 of fFAD in
BAE plus 1 % SDS determined in the present study is 1.82.
CD
CD analysis was done using a Chirascan CD spectrometer (Ap-
plied Photophysics Ltd.) and either a 1 mm (far UV) or 5 mm
(near UV) path-length quartz cuvette. Each spectrum repres-
ents an average of four independent scans with the spectra for
buffer alone subtracted. Thermal denaturation was measured at
222 nm in 1 ◦C intervals over 5 ◦C –90 ◦C, with a temperature
increase of 1 ◦C/min. Melting temperatures (Tm) were calculated
by obtaining the first derivative of each profile and finding the
maximum.
Fluorescence spectroscopy
Fluorescence measurements were recorded using a Cary Eclipse
fluorescence spectrophotometer (Varian Ltd.) in a 1 cm × 0.2 cm
path-length quartz cuvette. Thermal denaturation was followed
by the increase in FAD fluorescence at 535 nm after excitation at
455 nm, in 1 ◦C intervals between 5 ◦C –90 ◦C, with a temperature
increase of 1 ◦C/min.
Oxygen consumption assays
Erv1 oxidase activity was measured using a Clark-type oxy-
gen electrode (Hansatech Instrument Ltd) in a 0.5 ml of reaction
volume at 25 ◦C or 37 ◦C in BAE as previously described [6].
Data analysis of the oxygen consumption profile and the calcula-
tion of the reaction slope were performed using the MicrocalTM
OriginTM statistical software package.
Yeast complementation assays
A erv1 knockout strain containing WT ERV1 in a URA3 plasmid
[24] was co-transformed with WT or mutant ERV1 on TRP1
plasmid pRS414. For counter-selection tests, the strains were
spotted on 5-fluoroorotic acid (FOA) plates and incubated for up
to 2–3 days at 25 ◦C, 30 ◦C or 37 ◦C.
Miscellaneous
All experiments were carried out in BAE (150 mM NaCl, 50 mM
Tris/HCl, 1 mM EDTA, pH 7.4) unless specifically stated. For
multi-angle laser light-scattering, protein samples were applied
to a Superdex 200 10/30 gel filtration column (GE Health-
care) running with buffer A. Proteins eluting from the column
passed through an in-line DAWN EOS laser photometer set at
682 nm and an Optilab rEX refractor. To calculate the weight-
averaged molecular mass, the light scattering intensity and elu-
ent refractive index were analysed using ASTRA version 4.8
software.
MD simulations
MD simulations of the WT and Erv1W95F mutant were performed
using AMBER12 [29] with the protein modelled by the AM-
BER ff99SB force field [30] and the substrate FAD represented
using the parameters and partial charges developed by Asada
et al. [31]. The initial protein co-ordinate was taken from the
crystal structure of the C-terminal core domain (CTD) of Erv1
from Saccharomyces cerevisiae at 2.0 ˚A (1 ˚A = 0.1 nm) resol-
ution (PDB code: 4E0H) [11]. In the crystal structure, the CTD
of Erv1 exists as a homodimer, with each subunit formed of a
four-helix bundle that accommodates FAD binding. All crystal-
lographic waters were removed whereas hydrogens were added
using the LEAP program within AMBER12. The protein–FAD
complex consisting of 206 amino acid residues (103 residues
in each subunit) and two FADs was solvated in a rectangular
TIP3P water box with at least 8 ˚A between the edge of the box
and the protein. Chloride ions were added to neutralize the over-
all change of the system. Following minimization, the system
was heated to 298 K, equilibrated for 200 ps under the constant
pressure condition and the production simulation was performed
for 1 ns.
Calculation of binding free energy
The MM-GBSA approach [32,33] implemented in AMBER12
was used to study the FAD binding energy to Erv1 WT (EWT)
and Erv1W95F mutant (EW95F). A total of 500 frames from the
1-ns MD trajectory were used. The MM–GBSA free energy was
obtained from a combination of the gas phase molecular mech-
anics energy term (EMM = Eele + Evdw + Eint) and the solva-
tion free energy term (Gsolvation = Gpolar + Gnonpolar) without the
solute entropy term. The difference in the energy of FAD bind-
ing in the WT and W95F was derived by E = EW95F −
EWT.
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Figure 2 Sequence alignment of ERV/ALR homologues and structure of Erv1
Yeast complementation assays with tryptophan mutant Erv1 expression via plasmid shuffling in the absence and presence
of FOA. Strains containing empty vector or Erv1 WT were used as negative and positive controls respectively. Cells were
grown at 25 ◦C, 30 ◦C or 37 ◦C for 2–3 days.
RESULTS
Effects of Erv1 tryptophan mutations on yeast cell
viability
To investigate the requirement of individual tryptophan residues
of Erv1 in its function in vivo, we generated six tryptophan
mutant yeast strains by expressing plasmid-encoded erv1 single
tryptophan-to-phenylalanine mutants, in an ERV1 knockout strain
erv1, isogenic to the WT Trp303, as described previously [24].
Then, effects of the mutation on the cell viability were checked
by spot-testing at 25 ◦C, 30 ◦C and 37 ◦C (Figure 2). Upon
counter-selection of WT ERV1 (on URA3-containing plasmid),
the Erv1W95F mutant was temperature sensitive at both 30 ◦C and
37 ◦C, Erv1W183F grew normally at 25 ◦C and 30 ◦C, but slowly at
37 ◦C, whereas the other four mutants showed no obvious growth
defect at all three temperatures. This result confirmed that Trp95
and to a lesser extent Trp183 play important roles in the function
of Erv1 in vivo. The other four tryptophan residues, including
the highly conserved Trp157, were not important for cell viability
under these experimental conditions.
Effects of tryptophan mutations on the folding and
FAD-binding of Erv1
To understand the structural and functional roles of tryptophan
residues of Erv1, six single tryptophan-to-phenylalanine mutant
constructs of Erv1 were generated and expressed in E. coli. All
mutants were successfully purified using the same method as that
used for the WT protein, as described previously [6,17]. Gel filtra-
tion chromatography analysis showed that apart from Erv1W183F
all other five mutants eluted in the same or similar position as the
WT protein and thus existed mainly in a tetramer form like the
WT Erv1 [17,25] (Figure 3a; Supplementary Figure S1a). Elution
of Erv1W183F was delayed and the molecular mass of Erv1W183F
was determined using light scattering analysis to be 44 +− 3 kDa
(Supplementary Figure S1b), suggesting that Erv1W183F formed
a dimer (monomer Erv1 is 22 kDa).
Though there is a difference in oligomerization state, all six
mutants displayed the same yellowish colour as the WT pro-
tein and showed very similar overall UV-vis absorption spectra
profiles (Figure 3b). The visible absorption maximum λmax was
shifted most by Erv1W95F, from 460 nm (for WT) to 458 nm
(Table 1). The result suggests that FAD cofactor binding was
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Figure 3 Oligomerization state and absorption spectra of the WT
and tryptophan mutants of Erv1
(a) Gel filtration chromatography profiles of the WT (black line) and
six tryptphan mutants (as indicated) on a Superdex 200 column. (b)
UV-visible spectra of the WT and tryptophan mutants.
not significantly affected by the mutation. Consistently, similar
extinction coefficients were obtained as shown in Table 1, which
were determined by adding of 1 % SDS to release FAD as de-
scribed previously [6,7]. Moreover, FAD content of each purified
mutant was determined (see methods). Apart from Erv1W183F all
the other five mutants had ∼95 % FAD content, very similar com-
pared with the WT Erv1 and thus one FAD per monomer protein.
However, the FAD content of Erv1W183F decreased by more than
20 %, indicating that Trp183 and possibly also the tetramer form-
ation play a role in stabilizing cofactor binding.
Next, far and near UV CD analyses were carried out to invest-
igate the effects of the tryptophan mutants on the folding of Erv1.
The spectral profiles were compared with that of the WT protein
in relative intensity since they were different in their FAD con-
tent and thus holoprotein concentration. The far UV CD spectra
(Figure 4a) were normalized at 208 nm. Overall, all the spec-
tra showed characteristics of highly α-helical conformations, but
Figure 4 CD spectra of the WT and Trp mutants of Erv1
(a) Far UV CD spectra of 10 μM the WT (black line) and tryptophan
mutants. (b) Different spectra of the far UV CD spectra obtained by
subtraction of the mutant CD spectrum from that of the WT in (a). (c)
Near UV CD spectra of the WT and tryptophan mutants of Erv1. All the
colours were used systematically as in Figure 1.
with some differences in the region from 215 to 240 nm, espe-
cially for Erv1W95F and Erv1W183F. Subtraction of the Erv1W183F
spectrum from that of the WT gave a bell-shaped peak centred at
230 nm, characteristic of strong aromatic–aromatic interactions
(Figure 4b). In terms of the differences between the WT and
Erv1W95F spectra, apart from a positive peak at ∼230 nm, there
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Figure 5 FAD fluorescence spectra and thermal stability of the WT and tryptophan mutants of Erv1
(a and c) FAD fluorescence spectra (10 μM) of the WT, tryptophan mutants and fFAD measured at 5 ◦C before (a) and after (c)
thermal denaturation as shown in (b). (b) Thermal denaturation of the WT and mutant proteins followed by FAD fluorescence
with excitation at 450 nm and emission at 527 nm. (d). Relative total FAD fluorescence intensity (450–650 nm) of the
proteins before (black) and after (grey) thermal denaturation normalized to that of fFAD as 100 %.
was also a negative peak at ∼220 nm suggesting loss of some
α-helical structure in Erv1W95F. Similarly, clear differences in
the near UV CD spectra between the WT and these two mutants
(Erv1W95F and Erv1W183F) were observed (Figure 4c). The result
showed that the peak of Erv1 near UV CD at 285 nm was con-
tributed mainly by Trp95, whereas Trp183 seemed to contribute
to the peak at 295 nm significantly. Furthermore, the facts that
the near UV CD spectrum of Erv1W183F was closely similar to
that of Erv1R182H and that they both formed a dimer (rather than
tetramer) indicated that the signal at 295 nm may be associated
with formation of an Erv1tetramer.
Taken together, these results showed that both Trp95 and
Trp183 are structurally important in folding and FAD binding
of Erv1. Whereas Erv1W95F affected the secondary and ter-
tiary structure of Erv1 without affecting its oligomerization
state, Erv1W183F disrupted not only the oligomeric state, but
also the secondary structure and tertiary aromatic–aromatic in-
teractions and decreased FAD content under the experimental
conditions.
Effects of the tryptophan mutations on the stability
of Erv1
It has been shown that FAD release and thermal unfolding of
Erv1 are a co-operative process [25]. Thus, we investigated
how each tryptophan mutation affects the thermal stability of
the protein based on FAD fluorescence intensity change. Firstly,
FAD fluorescence spectra of the WT and six mutants and the
same concentration of fFAD were recorded at 5 ◦C. As shown
in Figure 5(a), whereas W95F displayed ∼20 % fFAD intensity,
negligible fluorescence intensity was detected for the WT and
other mutants due to Erv1 binding quenching FAD fluorescence.
Secondly, temperature-dependence of FAD fluorescence intens-
ity change and thus the cofactor release was measured (Figure 5b)
and the results were summarized in Table 1. Apart from W132F,
which showed the same midpoints of thermal denaturation (Tm)
of 64 ◦C as the WT Erv1, all other five mutants displayed de-
creased thermal stability. W95F is the most unstable mutant with
a Tm of 41 ◦C, which is 23 ◦C lower than that of the WT protein.
For W183F, Tm of 51 ◦C, a decrease of ∼13 ◦C was observed
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Table 2 Oxidase activity and cell viability of the WT and mutant Erv1
The activities were determined based on the initial oxygen consumption rate using that of the WT as 100 %. Oxygen consumption catalysed by
3 μM of the WT or a tryptophan mutant using 5 mM TCEP as the electron donor in the presence of SOD as described in the ‘Experimental’ section.
Errors represent means +− S.E.M., n  3.The cell growth phenotypes were determined based on spot-test shown in Figure 7.
Abbreviations: SOD, superoxide dismutase; ts, temperature sensitive.
Erv1 Activity at 25 ◦C Activity at 30 ◦C Activity at 37 ◦C Cell viability
WT 100 100 100 WT
W95F 53 +− 7 46 +− 5 9 +− 5 ts at 30 ◦C and 37 ◦C
W132F 90 +− 8 107 +− 5 99 +− 2 WT-like
W157F 84 +− 4 109 +− 12 98 +− 2 WT-like
W179F 95 +− 4 99 +− 5 102 +− 5 WT-like
W183F 102 +− 7 112 +− 5 53 +− 5 ts at 37 ◦C
W187F 108 +− 2 128 +− 5 118 +− 5 WT-like
(Table 1). W95F had the strongest effect on the stability of Erv1,
followed by W183F, W157F and the non-conserved tryptophan
mutants W179F, W187F, whereas W132F showed no obvious
effect on the thermal stability of Erv1 (Figure 5b; Table 1). This
order is not surprising, as the first three residues (W95F, W183F
and W157F) are highly conserved whereas the last three are not
(Figure 1). Similar Tm values were determined for the mutants
based on CD intensity change at 222 nm (Table 1), showing that
Erv1 unfolding and cofactor release was a coupled process.
To gain more understanding of the reversibility of the cofactor
binding, the FAD fluorescence spectra of the proteins after
thermal denaturation were re-recorded at 5 ◦C (Figure 5c). There
was little change to WT Erv1 and fFAD following renaturation.
However, clear FAD fluorescence intensity increases were ob-
served for all six mutants (Figures 5c and 5d), showing that there
was a defect in re-folding and/or cofactor binding in the mutants
after thermal denaturation. In summary, consistent with the con-
clusion above, temperature-dependent studies showed Erv1W95F
and Erv1W183F had the strongest effect on the stability of Erv1
and FAD-binding, though all six mutants displayed decreased
thermal stability of Erv1.
Effects of tryptophan mutations on Erv1 oxidase
activity
To understand the importance of the tryptophan residues in Erv1
function, the oxidase activity of the WT and mutants was ana-
lysed using oxygen consumption assay with 5 mM TCEP [tris-(2-
carboxyethyl) phosphine] as substrate as established previously
[25]. The relative activity of each mutant was calculated based on
their initial oxygen consumption rate compared with that of the
WT Erv1 (Table 2; Figure 6a). At 25 ◦C and 30 ◦C, only Erv1W95F
showed a clear functional defect, with ∼50 % activity of the WT
Erv1 (Table 2). At 37 ◦C, both Erv1W95F and Erv1W183F displayed
a significant functional defect; which Erv1W95F showed ∼9 %
and Erv1W183F had ∼53 % activity of the WT Erv1 respectively
(Figure 6a). Under the same conditions, the other four mutants,
including the highly conserved Trp157 mutant, showed no obvious
functional defect and Erv1W187F was slightly more active than the
WT Erv1 at all three temperatures. These results are consistent
with our in vivo findings and provide a good explanation for the
temperature sensitive growth phenotypes we observed (Figure 2).
Our previous study showed that the Erv1R182H, a disease re-
lated mutant, has stronger effects on folding and FAD-binding
of the catalytic reaction intermediates of Erv1 than the oxidized
steady state enzyme [25]. The cofactor was released readily from
Erv1R182H during its catalytic cycle leading to complete inactiv-
ation of the enzyme. In the present study, although only ∼30 %
of the oxidized Erv1W95F and 10 % of Erv1W183F were denatured
at 37 ◦C (Figure 5b), the activity loss was higher, ∼90 % and
50 % respectively. Thus, we reasoned that similar to Erv1R182H,
Erv1W95F and Erv1W183F had stronger destabilization effects on
folding and FAD-binding of the reaction intermediates than on
the initial oxidized Erv1. To test this hypothesis, the oxygen con-
sumption experiment was carried out in the presence of fFAD. As
expected, the oxidase activities of these mutants were recovered
by addition of fFAD and in a fFAD concentration dependent man-
ner (Figure 6b). Moreover, no obvious differences in the stability
of the oxidized enzymes were observed based on thermal denat-
uration studies. Tm of 66 +− 1 ◦C for the WT and 46 +− 2 ◦C for
the W95F mutant were obtained in the presence of 10 μM fFAD,
which are the same as those determined in the absence of fFAD
(Table 1).
Computational analysis
To understand the effects of W95F mutant on the stability of
FAD-binding further, MD simulations (See ‘Experimental’) of
the WT and Erv1W95F mutant were performed based on the
crystal structure of the CTD of Erv1 at 2.0 ˚A resolution (PDB
code: 4E0H) [11]. The overall FAD-binding energies of the WT
Erv1 [−71.1 +− 6.0 kcal/mol (1 cal ≡ 4.184 J)] and Erv1W95F
(−73.7 +− 4.7 kcal/mol), as calculated by the MM-GBSA method,
are similar. When the binding energy is decomposed into the
contribution of individual residues, key residues that contrib-
ute to FAD-binding are identified as shown in Figures 7(a) and
7(b). The residues include Gly91, Arg92, Trp95, Tyr128, Cys133,
Phe137, Cys159, His162, Val165, Lys171, Phe174, Arg182 and Trp183.
Consistently, these key residues are all located in proximity to
and interacting with the isoalloxazine ring, ribitol moiety and
adenosine moiety of FAD respectively (Supplementary Figure
S1). However, apparent differences in the contribution of indi-
vidual residues between the WT and the W95F mutant were
observed. The residues with significant binding energy changes
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Figure 6 Oxidase activity of the WT and tryptophan mutants of
Erv1
(a) The relative activities of the WT and six tryptophan mutants of Erv1
measured based on oxygen consumption at 37 ◦C. The activities were
normalized to that of the WT Erv1 as 100 %. All reactions contained
3 μM of the WT or mutant protein, using 5 mM TCEP as the electron
donor in the presence of SOD (superoxide dismutase). The initial rates
of oxygen consumption were used to calculate the relative activities.
Errors represent means +− S.E.M., n  3. (b) Time courses of oxygen
consumption at 37 ◦C catalysed by 1 μM of WT with/without addition
of 100 μM fFAD or 1 μM W95F mutant in the presence of various fFAD
concentrations as indicated in the figure.
(E > +−0.5 kcal/mol) are Val87, Arg92, Trp/Phe95, Tyr128,
Trp132, Cys133 and Lys171 (Figure 7c) and interestingly they are
all positioned in close proximity to the isoalloxazine ring of
FAD (Figure 7d). The result indicates that Trp95 plays a key role
in stabilizing the isoalloxazine ring in its positioning within the
binding site and how it interacts with key residues, such as Cys133
for which the binding energy to FAD is changed by 1.55 kcal/mol
in Erv1W95F (Figure 7c).
DISCUSSION
In the present report, we investigated the structural and func-
tional roles of all six tryptophan residues of Erv1, using yeast
genetic, biochemical and computational methods, with focus on
the highly conserved Trp95. We showed that all the tryptophan
mutants apart from W132F, had an impact on the thermal stability
of Erv1 as evidenced by their decreased Tm (Figure 5; Table 1).
In terms of function, the three non-conserved tryptophan residues
(Trp132, Trp179 and Trp187) and Trp157, a highly conserved residue
in the ERV/ALR sub-family, seem not to be essential for Erv1
function under normal cell growth or our experimental condi-
tions (Figure 1; Table 2). However, both Trp95 and Trp183 play
an important role in stabilizing the folding and FAD-binding and
thus the function of Erv1.
Mutagenesis studies of several FAD/FMN-dependent enzymes
suggested that aromatic residues forming π -stacking interactions
with the isoalloxazine ring of FAD/FMN help stabilize forma-
tion of the anionic flavin hydroquinone intermediate [34–36].
Similarly, in our study, mutating Trp95 into phenylalanine af-
fects the π–π repulsive interactions between the ring systems,
which may modulate the catalytic steps for the formation of
the S→FAD charge–transfer complexes. Our experimental res-
ults showed that Erv1W95F has the strongest effect on the sta-
bility and oxidase activity of Erv1. The functional defect of
Erv1W95F is largely due to the destabilizing effects on the cata-
lytic reaction intermediates since its activity can be recovered
and sustained by addition of fFAD in the reaction. This obser-
vation is consistent with the result of our computational ana-
lysis, suggesting that Trp95 is crucial in stabilizing the isoal-
loxazine ring to interact with Cys133, hence the redox centre
disulfide. Consequently, Erv1W95F mutation causes a strong func-
tional defect of Erv1 and impaired cell growth at both 30 ◦C
and 37 ◦C.
Trp183, on the other hand, is not directly involved in the π -
stacking network and only forms an H-bond with the nitrogen
of adenine moiety of FAD. This serves to maintain the orient-
ation of the adenine ring (FAD is in a bent conformation with
the isoalloxazine and the adenine ring buried in the active site
and sandwiched between Trp95 and His162). Therefore, mutating
Trp183 to phenylalanine is not as severe as W95F in terms of its
effect on Erv1 oxidase function (Table 2). However, Erv1W183F
showed a significant effect on the oligomerization state of Erv1,
which leads to a clear functional and growth defect at 37 ◦C but
not at 30 ◦C. This result is the same as that caused by Erv1R182H,
a disease related mutant, forming a dimer under the same ex-
perimental conditions [25]. The fact that both Arg182 and Trp183
are part of the fifth single turn α-helix (H5) of Erv1 shows that
this region is important in stabilizing the tetramer formation.
Furthermore, Arg182 may form intermolecular hydrogen bonds
to stabilize the tetramer formation, which may be assisted by a
typical side-chain cation–π interaction with Trp183. Since trypto-
phan is more favoured to interact with cationic side chains than
phenylalanine [37], we hypothesize that mutation of Trp183 dis-
rupts the cation–π interaction with Arg182, causing disruption
of the intermolecular interactions mediated by Arg182 and sub-
sequent dissociation of the tetrameric structure of Erv1. Such
a molecular mechanism of oligomerization formation has been
observed previously [38]. Together with the observation that pur-
ified W183F mutant showed a decreased FAD content than the
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Figure 7 Computational analysis
(a) Decomposition of the total FAD-binding energy into the contribution of individual residues for the WT Erv1 and (b) the
decomposition plot for Erv1W95F. (c) Changes in the energy of FAD binding by individual residues in the WT and W95F
(E = EW95F – EWT). Residues with E greater than +−0.5 kcal/mol are labelled. (d) Zoomed in structure of Erv1
showing residues whose binding energies to FAD are perturbed the most (|E| > 0.5 kcal/mol) by the W95F mutation
as shown in (c).
WT and other tryptophan mutants (Table 1), our results suggest
that tetramer formation plays an important role in stabilizing
the cofactor binding by Erv1 through the cation–π interaction
between Arg182 and Trp183 and Trp183’s contribution in maintain-
ing the π–π stacking network.
More generally, the aromatic ring stacking is conserved not
only in ERV/ALR family, but all FAD-dependent thiol oxidases,
including Ero1 (a thiol oxidase of the endoplasmic reticulum)
that has no sequence homology with ERV/ALR enzymes
[26,27,39]. Thus, it is tenable that the extensive π–π stacking
around FAD is the key to create a rigid active site to receive
electrons from the active-site disulfide (Cys130–Cys133) and pass
electrons to molecular oxygen. Taken together, the current study
contributes to our understanding of how thiol oxidases use FAD
to catalyse the disulfide bond formation and broadly, provide
insights into the function and mechanism of the structurally
diverse flavinenzymes.
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